Xenon Pharmaceuticals Inc. (NASDAQ:XENE) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...

In a June 24, 2025, podcast, Goldman Sachs’ Christian Mueller-Glissmann and Alexandra Wilson-Elizondo examined the dynamics ...

RBC expressed particular enthusiasm for ACP-204, described as a next-generation version of Nuplazid targeting more expansive neuropsychiatric disorders, with an estimated $940 million market ...

RBC Capital maintained its Outperform rating on Xenon Pharmaceuticals Inc. (NASDAQ:XENE) and increased its price target from $55 to $57 on June 13.

Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a late-stage trial.

Andrews N. Disorders of iron metabolism and sideroblastic anemia. In , eds Nathan D, Orkin S, Ginsberg Det al. Philadelphia, PA: Saunders; 2003. 456-497.

RBC indices such as mean corpuscular volume, mean corpuscular hemoglobin concentration, and red cell distribution width are laboratory parameters that are frequently overlooked in clinical practice.

People will frown at you; they will mock you and will often tell you go to bed earlier and not sleep on the job.

In this article, we identify the top 10 most impactful articles for pediatric hospital medicine in 2025, as presented at the ...